Literature DB >> 34341558

Belimumab an option for Black patients with SLE.

Joanna Clarke1.   

Abstract

Entities:  

Year:  2021        PMID： 34341558     DOI： 10.1038/s41584-021-00674-3

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus.

Authors:  Ellen Ginzler; Luiz Sergio Guedes Barbosa; David D'Cruz; Richard Furie; Kathleen Maksimowicz-McKinnon; James Oates; Mittermayer Barreto Santiago; Amit Saxena; Saira Sheikh; Damon L Bass; Susan W Burriss; Jennifer A Gilbride; James G Groark; Michelle Miller; Amy Pierce; David A Roth; Beulah Ji
Journal:  Arthritis Rheumatol       Date:  2021-12-09       Impact factor: 15.483
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.